Xilio Therapeutics, Inc. Share Price

Xilio Therapeutics, Inc. Share Price

NASDAQ: XLO | Micro Cap
$7.80
+$0.21 (2.70%) Last updated on 17 Nov, 2026 | 20:00 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Xilio Therapeutics, Inc. Stock Performance

Open
$7.80
Prev. Close
$7.60
Circuit Range
N/A
Day Range
$7.80 - $7.80
Year Range
$0.47 - $9.75
Volume
100
Average Traded
$7.80

Xilio Therapeutics, Inc. Share Price Today

As of 18 November 2026, Xilio Therapeutics, Inc.'s share price is $7.80. The stock opened at $7.80, compared to its previous close of $7.60. During today's trading session, Xilio Therapeutics, Inc.'s share price traded between $7.80 and $7.80, with an average price of $7.80. Over the past 52 weeks, the stock has recorded a high of $9.75 and a low of $0.47. In terms of performance, Xilio Therapeutics, Inc.'s share price has declined by 7.91% over the last six months and is up 937.90% on a year-on-year basis.

Xilio Therapeutics, Inc. Share Price Chart

Line chart of the Xilio Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 7.80 to 7.80, ending at 7.80.
$7.80$7.80
L
Show Current Price
H

Xilio Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$65.24M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.63
Revenue (TTM)
$43.77B
Return On Equity (TTM)
-16.84%
Profit Margin
-80.05%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-157.43%

Xilio Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$13.69$12.65$18.69$9.98
Net Profit$10.36-$9.53-$6.37-$5.95
Net Profit Margin75.68%-75.34%-34.08%-59.62%
Income ChangeN/A-191.99%33.16%6.59%

Xilio Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$6.34$43.77
Net Profit-$88.22-$76.40-$58.24-$35.04
Net Profit MarginN/AN/A-918.61%-80.05%
Income ChangeN/A13.40%23.77%39.84%

About Xilio Therapeutics, Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Xilio Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$7.82
$7.80
-4.12%
Oct 2026
$9.00
$8.14
-9.45%
Sep 2026
$9.05
$8.99
-1.69%
Aug 2026
$9.18
$9.14
-0.27%
Jul 2026
$9.08
$9.17
-3.22%
Jun 2026
$8.43
$9.47
+11.80%
May 2026
$8.43
$8.47
+6.47%
Apr 2026
$8.58
$7.96
-6.02%
Mar 2026
$0.52
$8.47
+1,495.10%
Feb 2026
$0.58
$0.53
-10.30%
Jan 2026
$0.64
$0.59
-7.93%
Dec 2025
$0.75
$0.64
-14.49%

XLO Share Price FAQs